FindTrial
Sign In

Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure

Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure (GREARTWAL Study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04062500
Acronym
GREARTWAL
Enrollment
10500
Registered
2019-08-20
Start date
2018-01-01
Completion date
2027-12-31
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart Failure,prognostic, registry

Brief summary

The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across China.

Detailed description

Registry for Longitudinal mortality and therapy in patients with Heart Failure is a large, multicenter, prospective, open-label registry of the management of patients treated in the hospital for acute heart failure in China. The objective of this study is to investigate the clinical features and prognosis of patients with heart failure, and discover the characteristics of high-risk heart failure patients, and elucidate critical factors which predict the development and outcomes of symptomatic heart failure patients. 1. To elucidate the clinical characteristics and prognostic risks of patients with heart failure. 2. To study the characteristics of high-risk heart failure patients and predict the key factors for the development of symptomatic heart failure patients. 3. To elucidate the compliance of patients with heart failure and the incidence of adverse drug effects. 4. To investigate the effect of self-management on outcomes in patients with heart failure. 5. To elucidate critical factors associated with the development and outcomes of heart failure. 6. To investigate hospitalization expenses for heart failure.

Interventions

OTHERMortality and Rehospitalization rate

Mortality and Re-hospitalization of acute decompensated heart failure

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Nanfang Hospital, Southern Medical University
CollaboratorOTHER
Beijing Chao Yang Hospital
CollaboratorOTHER
First Hospital of China Medical University
CollaboratorOTHER
Yangpu District Central Hospital Affiliated to Tongji University
CollaboratorOTHER
Xuhui Central Hospital, Shanghai
CollaboratorOTHER
Ningbo Medical Center Lihuili Hospital
CollaboratorOTHER_GOV
Shaanxi University of Chinese Medicine
CollaboratorOTHER
People's Hospital of Xinjiang Uygur Autonomous Region
CollaboratorOTHER
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
Shanghai 10th People's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

\- 1. 18 years and older. 2. Meet the diagnostic criteria of China 2018 or JACC/AHA 2017 or ESC 2016 heart failure guidelines. 3\. Agree to be tested and sign an informed consent certificate.

Exclusion criteria

* 1\. Age\<18 years old. 2. Patients who refused to participate. 3. Patients may have a life expectancy of less than 1 years due to non- heart failure clinical conditions.

Design outcomes

Primary

MeasureTime frameDescription
Mortality of acute decompensated heart failure10 yearsIn-hospital and Annual mortality
Re-hospitalization rate10 yearsRe-hospitalization of acute decompensated heart failure

Countries

China

Contacts

Primary ContactDachun Xu, PhD
xdc77@tongji.edu.cn18917684045

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026